Léa Wenger

I am CEO and Co-Founder of Cyclana Bio with a background in Veterinary Medicine and a PhD in Neuroscience from Cambridge University. After I was diagnosed with endometriosis myself, I started iterating jointly with my cofounder Prof. Kevin Chalut on the idea of how to apply our learnings to women's health. We are strongly driven by the desire to close the gender health gap through creating a flagship program for how to solve disease at the tissue level. Cyclana Bio has raised £5 million ($6.7 million) in 2025 to advance its drug discovery for endometriosis. The pre-seed funding round was co-led by NfX and Eka VC, with investors including Cocoa VC, Wilbe, and Angel investors.